Pharmacists brace for drug shortages and soaring costs [View all]
Source: Raw Story
May 18, 2025 5:15AM ET
In the dim basement of a Salt Lake City pharmacy, hundreds of amber-colored plastic pill bottles sit stacked in rows, one mans defensive wall in a tariff war. Independent pharmacist Benjamin Jolley and his colleagues worry that the tariffs, aimed at bringing drug production to the United States, could instead drive companies out of business while raising prices and creating more of the drug shortages that have plagued American patients for several years.
Jolley bought six months worth of the most expensive large bottles, hoping to shield his business from the 10% across-the-board tariffs on imported goods that President Donald Trump announced April 2. Now with threats of additional tariffs targeting pharmaceuticals, Jolley worries that costs will soar for the medications that will fill those bottles.
In principle, Jolley said, using tariffs to push manufacturing from China and India to the U.S. makes sense. In the event of war, China could quickly stop all exports to the United States. I understand the rationale for tariffs. Im not sure that were gonna do it the right way, Jolley said. And I am definitely sure that its going to raise the price that I pay my suppliers.
Squeezed by insurers and middlemen, independent pharmacists such as Jolley find themselves on the front lines of a tariff storm. Nearly everyone down the line drugmakers, pharmacies, wholesalers, and middlemen opposes most tariffs. Slashing drug imports could trigger widespread shortages, experts said, because of Americas dependence on Chinese- and Indian-made chemical ingredients, which form the critical building blocks of many medicines. Industry officials caution that steep tariffs on raw materials and finished pharmaceuticals could make drugs more expensive.
Read more: https://www.rawstory.com/tarrif/